Want deeper insights into Amgen's financial health and growth potential? InvestingPro offers exclusive analysis and metrics that go beyond surface-level data, with over 8 additional ProTips ...

InvestingPro analysis reveals that Amgen has maintained a robust gross profit margin of 68.71% and generated substantial levered free cash flow of $10.39 billion over the last twelve months.

Amgen also has a growing biosimilar portfolio. Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size ...

To create a more complete picture, I conducted a comparative analysis of the efficacy of MariTide with already FDA-approved medications. In my opinion, Amgen has a high chance of becoming on par ...

Here is where the DuPont analysis comes into play. It is an analytical method, which examines three major elements – operating management, management of assets and the capital structure ...

Want deeper insights into Amgen's financial health? InvestingPro subscribers get access to over 30 additional financial metrics and exclusive analysis, helping investors make more informed decisions.

InvestingPro analysis reveals that Amgen has maintained a robust gross profit margin of 68.71% and generated substantial levered free cash flow of $10.39 billion over the last twelve months. Looking ...